Literature DB >> 10890252

Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia.

R Domiati-Saad1, D B Dawson, L R Margraf, M J Finegold, A G Weinberg, B B Rogers.   

Abstract

The purpose of our study was to confirm reports of an association of human papillomavirus (HPV) with neonatal giant cell hepatitis (GCH) and biliary atresia (BA), and to expand these studies to include cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV6), and parvovirus B19 (PVB19). Frozen hepatic tissue was available for polymerase chain reaction (PCR) analysis in 19 cases of GCH or BA and 8 controls. Nested PCR to detect HPV types 6, 16, 18, and 33 was followed by 32P hybridization with generic probes. PCR followed by hybridization with a digoxigenin-labeled probe was used for all other viruses. HPV, EBV, and PVB19 were not detected in cases or controls. Two cases of GCH and 1 case of BA were PCR positive for CMV; controls were negative. HHV6 was detected in 6 cases: 2 GCH, 2 BA, and 2 controls. We conclude that HPV is not associated with GCH or BA. Detection of CMV in BA and GCH confirms other reports of this association. HHV6 requires further study to determine the significance of a positive PCR test in the livers of infants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890252     DOI: 10.1007/s100240010045

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  29 in total

1.  Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation.

Authors:  Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Gabriella B Gajdos; Pooja N Lineswala; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

Review 2.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 3.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

4.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

5.  Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia.

Authors:  Paula M Hertel; Sue E Crawford; Milton J Finegold; Mary K Estes
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

6.  A Point Mutation in the Rhesus Rotavirus VP4 Protein Generated through a Rotavirus Reverse Genetics System Attenuates Biliary Atresia in the Murine Model.

Authors:  Sujit K Mohanty; Bryan Donnelly; Phylicia Dupree; Inna Lobeck; Sarah Mowery; Jaroslaw Meller; Monica McNeal; Greg Tiao
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes.

Authors:  Inna Lobeck; Bryan Donnelly; Phylicia Dupree; Maxime M Mahe; Monica McNeal; Sujit K Mohanty; Greg Tiao
Journal:  Virology       Date:  2016-09-23       Impact factor: 3.616

8.  Incidence of hepatotropic viruses in biliary atresia.

Authors:  Stefan Rauschenfels; Miriam Krassmann; Ahmed N Al-Masri; Willem Verhagen; Johannes Leonhardt; Joachim F Kuebler; Claus Petersen
Journal:  Eur J Pediatr       Date:  2008-06-17       Impact factor: 3.183

Review 9.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.